-
1
-
-
0024327681
-
Calcium is required for the expression of anthrax lethal toxin activity in the macrophage like cell line J774A.1
-
Bhatnagar R., Singh Y., Leppla S. H., Friedlander A. M. Calcium is required for the expression of anthrax lethal toxin activity in the macrophage like cell line J774A.1. Infect. Immun. 57:1989;2107-2114.
-
(1989)
Infect. Immun.
, vol.57
, pp. 2107-2114
-
-
Bhatnagar, R.1
Singh, Y.2
Leppla, S.H.3
Friedlander, A.M.4
-
2
-
-
0028335856
-
Protein synthesis is required for expression of anthrax lethal toxin cytotoxicity
-
Bhatnagar R., Friedlander A. M. Protein synthesis is required for expression of anthrax lethal toxin cytotoxicity. Infect. Immun. 62:1994;2958-2962.
-
(1994)
Infect. Immun.
, vol.62
, pp. 2958-2962
-
-
Bhatnagar, R.1
Friedlander, A.M.2
-
3
-
-
0001370191
-
Field evaluation of human anthrax vaccine
-
Brachman P. S., Gold H., Plotkin S. A., Fekety F. R., Werrin M., Ingraham N. R. Field evaluation of human anthrax vaccine. Am. J. Public Health. 52:1962;632-645.
-
(1962)
Am. J. Public Health
, vol.52
, pp. 632-645
-
-
Brachman, P.S.1
Gold, H.2
Plotkin, S.A.3
Fekety, F.R.4
Werrin, M.5
Ingraham, N.R.6
-
4
-
-
0028091703
-
B. anthracis protective antigen, expressed in Salmonella typhimurium SL 3261, affords protection against anthrax spore challenge
-
Coulson M., Fulop M., Tidball R. W. B. anthracis protective antigen, expressed in Salmonella typhimurium SL 3261, affords protection against anthrax spore challenge. Vaccine. 12:1994;1395-1401.
-
(1994)
Vaccine
, vol.12
, pp. 1395-1401
-
-
Coulson, M.1
Fulop, M.2
Tidball, R.W.3
-
5
-
-
18244414803
-
Proteolytic inactivation of MAP Kinase Kinase by anthrax lethal factor
-
Duesbery N. S., Craig P. W., Leppla S. H., Gordon V. M., Klimpel K. R., Copeland T. W., Ahn N. G., Oskarsson M. K., Fukasawa K., Paull K. D., Woude G. F. V. Proteolytic inactivation of MAP Kinase Kinase by anthrax lethal factor. Science. 280:1998;734-737.
-
(1998)
Science
, vol.280
, pp. 734-737
-
-
Duesbery, N.S.1
Craig, P.W.2
Leppla, S.H.3
Gordon, V.M.4
Klimpel, K.R.5
Copeland, T.W.6
Ahn, N.G.7
Oskarsson, M.K.8
Fukasawa, K.9
Paull, K.D.10
Woude, G.F.V.11
-
6
-
-
0031910883
-
Fermentation, purification and characterization of protective antigen from a recombinant, avirulent strain of B. Anthracis
-
Farchaus J. W., Ribot W. J., Jendrek S., Little S. F. Fermentation, purification and characterization of protective antigen from a recombinant, avirulent strain of B. anthracis. Appl. Environ. Microbiol. 64:1998;982-991.
-
(1998)
Appl. Environ. Microbiol.
, vol.64
, pp. 982-991
-
-
Farchaus, J.W.1
Ribot, W.J.2
Jendrek, S.3
Little, S.F.4
-
7
-
-
0022891493
-
Macrophages are sensitive to anthrax toxin through an acid dependent process
-
Friedlander A. M. Macrophages are sensitive to anthrax toxin through an acid dependent process. J. Biol. Chem. 261:1986;7123-7126.
-
(1986)
J. Biol. Chem.
, vol.261
, pp. 7123-7126
-
-
Friedlander, A.M.1
-
8
-
-
0027470890
-
Characterization of macrophage sensitivity and resistance to anthrax lethal toxin
-
Friedlander A. M., Bhatnagar R., Leppla S. H., Singh Y. Characterization of macrophage sensitivity and resistance to anthrax lethal toxin. Infect. Immun. 61:1993;245-252.
-
(1993)
Infect. Immun.
, vol.61
, pp. 245-252
-
-
Friedlander, A.M.1
Bhatnagar, R.2
Leppla, S.H.3
Singh, Y.4
-
9
-
-
84925231914
-
Immunity to anthrax. Protective antigen present in cell free filtrates
-
Gladstone G. P. Immunity to anthrax. Protective antigen present in cell free filtrates. Br. J Exp. Pathol. 27:1946;349-418.
-
(1946)
Br. J Exp. Pathol.
, vol.27
, pp. 349-418
-
-
Gladstone, G.P.1
-
10
-
-
0021879151
-
Demonstration of a capsule plasmid in B. anthracis
-
Green B. D., Battisti L., Koehler T. M., Thorne C. B., Ivins B. E. Demonstration of a capsule plasmid in B. anthracis. Infect. Immun. 49:1985;291-297.
-
(1985)
Infect. Immun.
, vol.49
, pp. 291-297
-
-
Green, B.D.1
Battisti, L.2
Koehler, T.M.3
Thorne, C.B.4
Ivins, B.E.5
-
11
-
-
0031908230
-
Expression and purification of the recombinant lethal factor of Bacillus anthracis
-
Gupta P., Batra S., Chopra A. P., Singh Y., Bhatnagar R. Expression and purification of the recombinant lethal factor of Bacillus anthracis. Infect Immun. 66:1998;862-865.
-
(1998)
Infect Immun.
, vol.66
, pp. 862-865
-
-
Gupta, P.1
Batra, S.2
Chopra, A.P.3
Singh, Y.4
Bhatnagar, R.5
-
12
-
-
0021205725
-
Anthrax: The disease in relation to vaccines
-
Hambleton P., Craman J. A., Melling J. Anthrax: the disease in relation to vaccines. Vaccine. 2:1984;125-132.
-
(1984)
Vaccine
, vol.2
, pp. 125-132
-
-
Hambleton, P.1
Craman, J.A.2
Melling, J.3
-
13
-
-
0027097608
-
Biochemical and physiological changes induced by anthrax lethal toxin in J774A.1 macrophage like cells
-
Hanna P. C., Kochi S., Collier R. F. Biochemical and physiological changes induced by anthrax lethal toxin in J774A.1 macrophage like cells. Mol. Biol. Cell. 3:1992;1269-1277.
-
(1992)
Mol. Biol. Cell
, vol.3
, pp. 1269-1277
-
-
Hanna, P.C.1
Kochi, S.2
Collier, R.F.3
-
14
-
-
0025095447
-
Expression of Bacillus anthracis protective antigen by baculovirus and vaccinia virus recombinants
-
Iacono-Connors L. C., Schmaljohn C. S., Dalrymple J. M. Expression of Bacillus anthracis protective antigen by baculovirus and vaccinia virus recombinants. Infect. Immun. 58:1990;366-372.
-
(1990)
Infect. Immun.
, vol.58
, pp. 366-372
-
-
Iacono-Connors, L.C.1
Schmaljohn, C.S.2
Dalrymple, J.M.3
-
15
-
-
0022627840
-
Immunization studies with attenuated strains of Bacillus anthracis
-
Ivins B. I., Ezzel J. W., Jemski J., Ristroph J. D., Leppla S. H. Immunization studies with attenuated strains of Bacillus anthracis. Infect. Immun. 52:1986;454-458.
-
(1986)
Infect. Immun.
, vol.52
, pp. 454-458
-
-
Ivins, B.I.1
Ezzel, J.W.2
Jemski, J.3
Ristroph, J.D.4
Leppla, S.H.5
-
16
-
-
0028061210
-
Efficacy of standard human anthrax vaccine against B. anthracis spore challenge in guinea pigs
-
Ivins B. E., Fellows P. F., Nelson G. O. Efficacy of standard human anthrax vaccine against B. anthracis spore challenge in guinea pigs. Vaccine. 12:1994;872-874.
-
(1994)
Vaccine
, vol.12
, pp. 872-874
-
-
Ivins, B.E.1
Fellows, P.F.2
Nelson, G.O.3
-
17
-
-
0023924122
-
Recent advances in the development of an improved human anthrax vaccine
-
Ivins B. E., Welkos S. L. Recent advances in the development of an improved human anthrax vaccine. Eur. J. Epidemol. 4:1987;12-19.
-
(1987)
Eur. J. Epidemol.
, vol.4
, pp. 12-19
-
-
Ivins, B.E.1
Welkos, S.L.2
-
18
-
-
0023022205
-
Cloning and expression of the B. anthracis protective antigen gene in B. subtilis
-
Ivins B. E., Welkos S. L. Cloning and expression of the B. anthracis protective antigen gene in B. subtilis. Infect. Immun. 54:1986;537-542.
-
(1986)
Infect. Immun.
, vol.54
, pp. 537-542
-
-
Ivins, B.E.1
Welkos, S.L.2
-
19
-
-
0026498189
-
Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin
-
Klimpel R. K., Molloy S. S., Thomas G., Leppla S. H. Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin. Proc. Natl. Acad. Sci. USA. 89:1992;10277-10281.
-
(1992)
Proc. Natl. Acad. Sci. USA
, vol.89
, pp. 10277-10281
-
-
Klimpel, R.K.1
Molloy, S.S.2
Thomas, G.3
Leppla, S.H.4
-
20
-
-
0000947082
-
Anthrax toxin edema factor: A bacterial adenylate cyclase that increases cAMP conc. in eukaryotic cells
-
Leppla S. H. Anthrax toxin edema factor: A bacterial adenylate cyclase that increases cAMP conc. in eukaryotic cells. Proc. Natl. Acad. Sci. USA. 79:1982;3162-3166.
-
(1982)
Proc. Natl. Acad. Sci. USA
, vol.79
, pp. 3162-3166
-
-
Leppla, S.H.1
-
21
-
-
0024214705
-
Production and purification of anthrax toxin
-
S. Harshman. San Diego: Academic Press
-
Leppla S. H. Production and purification of anthrax toxin. Harshman S. Methods in Enzymology. 1988;103-116 Academic Press, San Diego.
-
(1988)
Methods in Enzymology
, pp. 103-116
-
-
Leppla, S.H.1
-
22
-
-
0002661972
-
The anthrax toxin complex
-
J. E. Alouf, & J. H. Freer. London: Academic Press
-
Leppla S. H. The anthrax toxin complex. Alouf J. E., Freer J. H. Sourcebook of Bacterial Protein Toxins. 1991;277-302 Academic Press, London.
-
(1991)
Sourcebook of Bacterial Protein Toxins
, pp. 277-302
-
-
Leppla, S.H.1
-
25
-
-
0032078170
-
Protective efficacy of a recombinant protective antigen against B. anthracis challenge and assessment of immunological markers
-
McBride B. W., Mogg A., Telfer J. L., Lever M. S., Miller J., Turnbull P. C. B., Baillie L. Protective efficacy of a recombinant protective antigen against B. anthracis challenge and assessment of immunological markers. Vaccine. 16:1998;810-817.
-
(1998)
Vaccine
, vol.16
, pp. 810-817
-
-
McBride, B.W.1
Mogg, A.2
Telfer, J.L.3
Lever, M.S.4
Miller, J.5
Turnbull, P.C.B.6
Baillie, L.7
-
27
-
-
0002734057
-
Plasmids of Bacillus anthracis
-
L. Leive. Washington: Am. Soc. Microbiol.
-
Mikesell O. P., Vodkin M. Plasmids of Bacillus anthracis. Leive L. Microbiology. 1985;52-55 Am. Soc. Microbiol. Washington.
-
(1985)
Microbiology
, pp. 52-55
-
-
Mikesell, O.P.1
Vodkin, M.2
-
28
-
-
0031931788
-
Production and purification of recombinant protective antigen and protective efficacy against Bacillus anthracis
-
Miller J., McBride B. W., Manchee R. J., Moore P., Baille L. W. J. Production and purification of recombinant protective antigen and protective efficacy against Bacillus anthracis. Lett. Appl. Microbiol. 26:1998;56-60.
-
(1998)
Lett. Appl. Microbiol.
, vol.26
, pp. 56-60
-
-
Miller, J.1
McBride, B.W.2
Manchee, R.J.3
Moore, P.4
Baille, L.W.J.5
-
29
-
-
0028018856
-
Anthrax protective antigen forms oligomers during intoxication of mammalian cells
-
Milne J. C., Furlong D., Hanna P. C., Wall J. S., Collier R. J. Anthrax protective antigen forms oligomers during intoxication of mammalian cells. J. Biol. Chem. 269:1994;20607-20612.
-
(1994)
J. Biol. Chem.
, vol.269
, pp. 20607-20612
-
-
Milne, J.C.1
Furlong, D.2
Hanna, P.C.3
Wall, J.S.4
Collier, R.J.5
-
30
-
-
0025747514
-
Functional mapping of anthrax toxin lethal factor by in frame insertion mutagenesis
-
Quinn P. C., Singh Y., Klimpel R. K., Leppla S. H. Functional mapping of anthrax toxin lethal factor by in frame insertion mutagenesis. J. Biol. Chem. 266:1991;20124-20130.
-
(1991)
J. Biol. Chem.
, vol.266
, pp. 20124-20130
-
-
Quinn, P.C.1
Singh, Y.2
Klimpel, R.K.3
Leppla, S.H.4
-
31
-
-
0023911589
-
Purification of anthrax toxin components by high performance anion-exchange, gel filtration and hydrophobic interaction chromatography
-
Quinn P. C., Shone C. C., Turnbell T. B., Melling J. Purification of anthrax toxin components by high performance anion-exchange, gel filtration and hydrophobic interaction chromatography. Biochem. J. 252:1988;753-758.
-
(1988)
Biochem. J.
, vol.252
, pp. 753-758
-
-
Quinn, P.C.1
Shone, C.C.2
Turnbell, T.B.3
Melling, J.4
-
32
-
-
0030271170
-
Thermostabilization of protective antigen - The binding component of anthrax lethal toxin
-
Radha C., Salotra P., Bhat R., Bhatnagar R. Thermostabilization of protective antigen - the binding component of anthrax lethal toxin. J. Biotech. 50:1996;235-242.
-
(1996)
J. Biotech.
, vol.50
, pp. 235-242
-
-
Radha, C.1
Salotra, P.2
Bhat, R.3
Bhatnagar, R.4
-
33
-
-
0002330206
-
Toxin structure and function
-
C. B. Saelinger. Boca Raton: CRC Press
-
Saelinger C. B. Toxin structure and function. Saelinger C. B. Trafficking of Bacterial Toxins. 1990;1-14 CRC Press, Boca Raton.
-
(1990)
Trafficking of Bacterial Toxins
, pp. 1-14
-
-
Saelinger, C.B.1
-
35
-
-
0030087551
-
Expression and purification of anthrax toxin protective antigen from E. coli
-
Sharma M., Swain P. K., Chopra A. P., Chaudhary V. K., Singh Y. Expression and purification of anthrax toxin protective antigen from E. coli. Protein Exp. Purif. 7:1996;33-38.
-
(1996)
Protein Exp. Purif.
, vol.7
, pp. 33-38
-
-
Sharma, M.1
Swain, P.K.2
Chopra, A.P.3
Chaudhary, V.K.4
Singh, Y.5
-
36
-
-
0028175130
-
Human live anthrax vaccine in the former USSR
-
Shlyakhov E. N., Rubinstein E. Human live anthrax vaccine in the former USSR. Vaccine. 12:1993;727-730.
-
(1993)
Vaccine
, vol.12
, pp. 727-730
-
-
Shlyakhov, E.N.1
Rubinstein, E.2
-
37
-
-
0024837128
-
A deleted variant of B. anthracis protective antigen is non toxic and blocks anthrax toxin action in vivo
-
Singh Y., Chaudhary V. K., Leppla S. H. A deleted variant of B. anthracis protective antigen is non toxic and blocks anthrax toxin action in vivo. J. Biol. Chem. 264:1989;19103-19107.
-
(1989)
J. Biol. Chem.
, vol.264
, pp. 19103-19107
-
-
Singh, Y.1
Chaudhary, V.K.2
Leppla, S.H.3
-
38
-
-
0001731185
-
Observations on experimental anthrax: Demonstration of a specific lethal factor produced in vivo by Bacillus anthracis
-
Smith H., Keppie J. Observations on experimental anthrax: demonstration of a specific lethal factor produced in vivo by Bacillus anthracis. Nature. 173:1954;869-870.
-
(1954)
Nature
, vol.173
, pp. 869-870
-
-
Smith, H.1
Keppie, J.2
-
39
-
-
0000823104
-
The chemical basis of virulence of Bacillus anthracis V. The specific toxin produced by B. anthracis in vivo
-
Smith H., Keppie J., Stanley J. L. The chemical basis of virulence of Bacillus anthracis V. The specific toxin produced by B. anthracis in vivo. Br. J. Exp. Pathol. 36:1955;460-472.
-
(1955)
Br. J. Exp. Pathol.
, vol.36
, pp. 460-472
-
-
Smith, H.1
Keppie, J.2
Stanley, J.L.3
-
40
-
-
73049164375
-
Purification of factor I and recognition of a third factor of anthrax toxin
-
Stanley J. L., Smith H. Purification of factor I and recognition of a third factor of anthrax toxin. J. Gen. Microbiol. 26:1961;49-66.
-
(1961)
J. Gen. Microbiol.
, vol.26
, pp. 49-66
-
-
Stanley, J.L.1
Smith, H.2
-
41
-
-
0025868227
-
Anthrax vaccines: Past, present and future
-
Turnbull P. C. B. Anthrax vaccines: past, present and future. Vaccine. 9:1992;533-539.
-
(1992)
Vaccine
, vol.9
, pp. 533-539
-
-
Turnbull, P.C.B.1
-
42
-
-
0020826341
-
Cloning of the protective antigen gene of B. anthracis
-
Vodkin M. H., Leppla S. H. Cloning of the protective antigen gene of B. anthracis. Cell. 34:1983;693-697.
-
(1983)
Cell
, vol.34
, pp. 693-697
-
-
Vodkin, M.H.1
Leppla, S.H.2
-
43
-
-
0023811218
-
Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice
-
Welkos S. L., Friedlander A. M. Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice. Microb. Pathogen. 5:1988;127-139.
-
(1988)
Microb. Pathogen.
, vol.5
, pp. 127-139
-
-
Welkos, S.L.1
Friedlander, A.M.2
-
44
-
-
0023758535
-
Sequence and analysis of the DNA encoding protective antigen of Bacillus anthracis
-
Welkos S. L., Lowe J. R., Eden-McCutchan F., Vodkin M., Leppla S. H. Sequence and analysis of the DNA encoding protective antigen of Bacillus anthracis. Gene. 69:1988;287-300.
-
(1988)
Gene
, vol.69
, pp. 287-300
-
-
Welkos, S.L.1
Lowe, J.R.2
Eden-McCutchan, F.3
Vodkin, M.4
Leppla, S.H.5
|